BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19026138)

  • 1. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract]   [Full Text] [Related]  

  • 2. Worsening of osteomalacia in a patient successfully treated for neuro-Behçet's disease with infliximab.
    Madanat WY; Madanat AY
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S128-9. PubMed ID: 19026133
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
    Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
    Ariyachaipanich A; Berkelhammer C; Nicola H
    Inflamm Bowel Dis; 2009 Dec; 15(12):1769-71. PubMed ID: 19177427
    [No Abstract]   [Full Text] [Related]  

  • 7. Adalimumab for sight-threatening uveitis in Behçet's disease.
    Mushtaq B; Saeed T; Situnayake RD; Murray PI
    Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 10. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
    Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
    Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
    Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of adalimumab in Behçet's disease. Description of 6 cases].
    Calvo Catalá J; Campos Fernández C; Rueda Cid A; González-Cruz Cervellera MI; Baixauli Rubio A; Pastor Cubillo MD
    Reumatol Clin; 2011; 7(4):258-61. PubMed ID: 21794828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urticaria and angioedema in a patient with Behçet's disease treated with adalimumab.
    Sànchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N; Ruiz-Villaverde R
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S128. PubMed ID: 17067448
    [No Abstract]   [Full Text] [Related]  

  • 15. Adalimumab: a new modality for Behçet's disease?
    van Laar JA; Missotten T; van Daele PL; Jamnitski A; Baarsma GS; van Hagen PM
    Ann Rheum Dis; 2007 Apr; 66(4):565-6. PubMed ID: 17124248
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
    Atzeni F; Leccese P; D'Angelo S; Sarzi-Puttini P; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S94. PubMed ID: 20868581
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of long-standing neuro-Behçet's disease with infliximab.
    Sarwar H; McGrath H; Espinoza LR
    J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS; Gavin MP; Sturrock RD
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.